← FDA ENFORCEMENT
D-1139-2023Class III

Contract Pharmaceuticals Limited Canada

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
Contract Pharmaceuticals Limited Canada
Product type
Drug
Status
Terminated
Report date
2023-09-06
Distribution
Nationwide in the USA.
Firm state
N/A
Product quantity
11,350 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall

Defective Container: slow leakage under the cap

Product description

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

Code / lot info

Lot # 118920, exp. January 2024.

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →